203 related articles for article (PubMed ID: 25759166)
1. Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson's disease.
Madhyastha TM; Askren MK; Boord P; Zhang J; Leverenz JB; Grabowski TJ
Mov Disord; 2015 Dec; 30(14):1893-900. PubMed ID: 25759166
[TBL] [Abstract][Full Text] [Related]
2. Patterns of cortical thinning in nondemented Parkinson's disease patients.
Uribe C; Segura B; Baggio HC; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
Mov Disord; 2016 May; 31(5):699-708. PubMed ID: 27094093
[TBL] [Abstract][Full Text] [Related]
3. Cortical thinning is associated with disease stages and dementia in Parkinson's disease.
Zarei M; Ibarretxe-Bilbao N; Compta Y; Hough M; Junque C; Bargallo N; Tolosa E; Martí MJ
J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):875-81. PubMed ID: 23463873
[TBL] [Abstract][Full Text] [Related]
4. Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia.
Lyoo CH; Ryu YH; Lee MS
Mov Disord; 2010 Mar; 25(4):496-9. PubMed ID: 20108369
[TBL] [Abstract][Full Text] [Related]
5. Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis.
Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Tolosa E; Junque C
Parkinsonism Relat Disord; 2018 May; 50():3-9. PubMed ID: 29449187
[TBL] [Abstract][Full Text] [Related]
6. Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-up.
Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
Parkinsonism Relat Disord; 2019 Jul; 64():286-292. PubMed ID: 31103485
[TBL] [Abstract][Full Text] [Related]
7. Cortical thinning associated with mild cognitive impairment in Parkinson's disease.
Segura B; Baggio HC; Marti MJ; Valldeoriola F; Compta Y; Garcia-Diaz AI; Vendrell P; Bargallo N; Tolosa E; Junque C
Mov Disord; 2014 Oct; 29(12):1495-503. PubMed ID: 25100674
[TBL] [Abstract][Full Text] [Related]
8. Cortical thinning across Parkinson's disease stages and clinical correlates.
Wilson H; Niccolini F; Pellicano C; Politis M
J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
[TBL] [Abstract][Full Text] [Related]
9. Patterns of cortical thickness and surface area in early Parkinson's disease.
Jubault T; Gagnon JF; Karama S; Ptito A; Lafontaine AL; Evans AC; Monchi O
Neuroimage; 2011 Mar; 55(2):462-7. PubMed ID: 21184830
[TBL] [Abstract][Full Text] [Related]
10. Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality.
Danti S; Toschi N; Diciotti S; Tessa C; Poletti M; Del Dotto P; Lucetti C
Eur J Neurol; 2015 Dec; 22(12):1564-72. PubMed ID: 26212370
[TBL] [Abstract][Full Text] [Related]
11. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
[TBL] [Abstract][Full Text] [Related]
12. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
[TBL] [Abstract][Full Text] [Related]
13. Initial cognitive decline is associated with cortical thinning in early Parkinson disease.
Pereira JB; Svenningsson P; Weintraub D; Brønnick K; Lebedev A; Westman E; Aarsland D
Neurology; 2014 Jun; 82(22):2017-25. PubMed ID: 24808018
[TBL] [Abstract][Full Text] [Related]
14. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease.
Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
Neurobiol Dis; 2019 Apr; 124():29-35. PubMed ID: 30408592
[TBL] [Abstract][Full Text] [Related]
16. Cortical structural involvement and cognitive dysfunction in early Parkinson's disease.
Klein JC; Rolinski M; Griffanti L; Szewczyk-Krolikowski K; Baig F; Ruffmann C; Groves AR; Menke RAL; Hu MT; Mackay C
NMR Biomed; 2018 Apr; 31(4):e3900. PubMed ID: 29436039
[TBL] [Abstract][Full Text] [Related]
17. Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease.
Pagonabarraga J; Corcuera-Solano I; Vives-Gilabert Y; Llebaria G; García-Sánchez C; Pascual-Sedano B; Delfino M; Kulisevsky J; Gómez-Ansón B
PLoS One; 2013; 8(1):e54980. PubMed ID: 23359616
[TBL] [Abstract][Full Text] [Related]
18. Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
Ye BS; Jeon S; Yoon S; Kang SW; Baik K; Lee Y; Chung SJ; Oh JS; Moon H; Kim JS; Lee PH; Sohn YH
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):197-204. PubMed ID: 28951497
[TBL] [Abstract][Full Text] [Related]
19. Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.
Chung SJ; Yoo HS; Lee YH; Lee HS; Ye BS; Sohn YH; Kwon H; Lee PH
Hum Brain Mapp; 2019 Sep; 40(13):3784-3794. PubMed ID: 31090134
[TBL] [Abstract][Full Text] [Related]
20. Topographic pattern of cortical thinning with consideration of motor laterality in Parkinson disease.
Kim JS; Yang JJ; Lee JM; Youn J; Kim JM; Cho JW
Parkinsonism Relat Disord; 2014 Nov; 20(11):1186-90. PubMed ID: 25231669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
